Patent · US Active

Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments

US7750005B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Stefanie Flohr · Basel, CH
Siegfried Stengelin · Frankfurt am Main, DE
Matthias Gossel · Frankfurt am Main, DE
Thomas Klabunde · Frankfurt, DE
Pavel Safar · Tucson, US
James Spoonamore · Tucson, US
Martin Smrcina · Tucson, US

Key dates

Filing date	May 21, 2008
Grant date	Jul 6, 2010
Priority date	—
Expiry date	May 21, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof.Compounds of the formula Iin which the radicals have the stated meanings, and the physiologically tolerated salts thereof and processes for preparing them are described. The compounds are suitable for example as anorectic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.